| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/04/2007 | WO2007002637A1 N-linked heterocyclic antagonists of p2y1 receptor useful in the treatment of thrombotic conditions |
| 01/04/2007 | WO2007002634A1 Carbocycle and heterocycle antagonists of p2y1 receptor useful in the treatment of thrombotic conditions |
| 01/04/2007 | WO2007002597A2 Modified-release formulations of a bupropion salt |
| 01/04/2007 | WO2007002587A2 Inhibitors of epstein barr virus nuclear antigen 1 |
| 01/04/2007 | WO2007002584A1 Linear urea mimics antagonists of p2y1 receptor useful in the treatment of thrombotic conditions |
| 01/04/2007 | WO2007002563A1 Imidazole based lxr modulators |
| 01/04/2007 | WO2007002559A1 Pyrazole based lxr modulators |
| 01/04/2007 | WO2007002557A1 Niacin receptor agonists, compositions containing such compounds and methods of treatment |
| 01/04/2007 | WO2007002518A1 Delayed release or extended-delayed release dosage forms of pramipexole |
| 01/04/2007 | WO2007002516A2 Improved dosage forms for movement disorder treatment |
| 01/04/2007 | WO2007002497A1 Method of treating neurological disorders using clotrimazole and derivatives thereof |
| 01/04/2007 | WO2007002481A2 Non-nucleoside reverse transcriptase inhibitors |
| 01/04/2007 | WO2007002462A2 Crystalline forms of mc4r agonist and process for synthesis |
| 01/04/2007 | WO2007002461A1 3,4-substituted thiazoles as ampk activators |
| 01/04/2007 | WO2007002458A2 Non-nucleoside reverse transcriptase inhibitors |
| 01/04/2007 | WO2007002457A2 Hydroisoindoline tachykinin receptor antagonists |
| 01/04/2007 | WO2007002447A2 Compositions for treating rosacea |
| 01/04/2007 | WO2007002444A1 Thiol-sensitive positive inotropes |
| 01/04/2007 | WO2007002441A1 Methods of use for non-atp competitive tyrosine kinase inhibitors to treat pathogenic infection |
| 01/04/2007 | WO2007002433A1 Pyrrolo [2, 3-b] pyridine derivatives as protein kinase inhibitors |
| 01/04/2007 | WO2007002411A1 Antiviral compounds |
| 01/04/2007 | WO2007002410A2 Core-modified terpene trilactones from ginkgo biloba extract and biological evaluation thereof |
| 01/04/2007 | WO2007002368A2 Non-nucleoside reverse transcriptase inhibitors |
| 01/04/2007 | WO2007002365A2 Modulation of amino acid metabolism in the hypothalamus |
| 01/04/2007 | WO2007002361A2 3-fluoro-piperidine t-type calcium channel antagonists |
| 01/04/2007 | WO2007002325A1 Pyrrolo[2,3-b] pyridine derivatives as protein kinase inhibitors |
| 01/04/2007 | WO2007002314A2 Polymorphic forms of tegaserod maleate |
| 01/04/2007 | WO2007002294A2 Composition for enhancing cellular energy |
| 01/04/2007 | WO2007002293A2 Azaindazole compounds and methods of use |
| 01/04/2007 | WO2007002272A1 Benzopyranone compounds for treating cancer |
| 01/04/2007 | WO2007002222A2 Psma antibody-drug conjugates |
| 01/04/2007 | WO2007002191A2 Methods for the preparation of 9-deazapurine derivatives |
| 01/04/2007 | WO2007002174A2 A method of treatment of hormone depletion induced vasomotor symptoms |
| 01/04/2007 | WO2007002173A1 Hiv-1 protease inhibitors, and methods of making and using them |
| 01/04/2007 | WO2007002172A2 Hiv-1 protease inhibitors |
| 01/04/2007 | WO2007002157A2 Process for preparing benzimidazole compounds |
| 01/04/2007 | WO2007002139A2 Neuroprotection of retinal ganglion cells |
| 01/04/2007 | WO2007002126A1 Alkyl sulfonamide derivatives |
| 01/04/2007 | WO2007002125A1 Rapidly absorbing oral formulations of pde5 inhibitors |
| 01/04/2007 | WO2007002120A2 Fungicidal effect by regulating signal transduction pathways |
| 01/04/2007 | WO2007002114A1 1,2-dihydro-spiro(3h-indole-3-4’-piperidine) compounds as modulators of the mas receptor novel |
| 01/04/2007 | WO2007002092A1 SNAr PROCESS FOR PREPARING BENZIMIDAZOLE COMPOUNDS |
| 01/04/2007 | WO2007002051A1 Carboline derivatives and their use as inhibitors of flaviviridae infections |
| 01/04/2007 | WO2007001973A1 New use |
| 01/04/2007 | WO2007001961A2 Method for the treatment of acne |
| 01/04/2007 | WO2007001939A1 Tetrahydro-pyranopyrazole compounds displaying cannabinoid modulating activities |
| 01/04/2007 | WO2007001932A2 Substituted isothiazolones as inhibitors of cytosolic phospholipase a2 |
| 01/04/2007 | WO2007001891A1 Transdermal delivery of cannabinoids |
| 01/04/2007 | WO2007001883A2 Method to reduce oxidative damage and improve mitochondrial efficiency |
| 01/04/2007 | WO2007001841A1 Treatment of sexual dysfunction |
| 01/04/2007 | WO2007001818A2 Substituted isoindole-1,3-diones |
| 01/04/2007 | WO2007001685A2 Synergistic cinnamon combinations and methods for enhancing insulin activity |
| 01/04/2007 | WO2007001684A2 Inhibiting dna polymerase beta to enhance efficacy of anticancer agents |
| 01/04/2007 | WO2007001671A1 Use of 3- or 7-thia- or 3 , 7-ditηiapr0sten0ic acid derivatives for the treatment of inflammatory bowel disease |
| 01/04/2007 | WO2007001506A1 Composition and method of protection against uv irradiation |
| 01/04/2007 | WO2007001455A2 Hydrophobic polyamine amides as potent lipopolysaccharide sequestrants |
| 01/04/2007 | WO2007001395A2 Prevention and treatment of influenza with glutamine antagonist agents |
| 01/04/2007 | WO2007001339A2 Ambient stored blood plasma expanders |
| 01/04/2007 | WO2007001323A2 Methods and compositions for inhibiting, destroying, and/or inactivating viruses |
| 01/04/2007 | WO2007001302A1 Delivery of active proteins to the central nervous system using phage vectors |
| 01/04/2007 | WO2007001300A1 Multiple active drug-resin conjugate |
| 01/04/2007 | WO2007001249A1 Nitrogen heterocycle biaryls for osteoporosis and other diseases |
| 01/04/2007 | WO2007001225A1 Thiophene-2-carboxamide derivatives as alpha 7 nicotinic receptor modulators. |
| 01/04/2007 | WO2007001150A2 Method for preventing and treating conditions mediated by ppar using macelignan |
| 01/04/2007 | WO2007001139A1 A composition for treating or preventing a cancer comprising pyrrolopyridine derivatives |
| 01/04/2007 | WO2007001086A1 Orally disintegrating powder comprising cilostazol and mannitol |
| 01/04/2007 | WO2007001067A2 Solid dosage form comprising an angiotensin ii receptor antagonist and a calcium channel blocker |
| 01/04/2007 | WO2007001065A2 Method for the preparation of a wet granulated drug product |
| 01/04/2007 | WO2007001058A1 Herpesvirus-derived therapeutic agent for pain |
| 01/04/2007 | WO2007001049A1 Benzenoid ansamycin derivative |
| 01/04/2007 | WO2007001010A1 Pharmaceutical for treatment of parkinson’s disease |
| 01/04/2007 | WO2007000998A1 BIS(ARYLMETHYLIDENE)ACETONE COMPOUND, ANTI-CANCER AGENT, CARCINOGENESIS-PREVENTIVE AGENT, INHIBITOR OF EXPRESSION OF Ki-Ras, ErbB2, c-Myc AND CYCLINE D1, β-CATENIN-DEGRADING AGENT, AND p53 EXPRESSION ENHANCER |
| 01/04/2007 | WO2007000985A1 Prophylactic or therapeutic composition for hemoglobinuria or myoglobinuria |
| 01/04/2007 | WO2007000970A1 Therapeutic agent for pain |
| 01/04/2007 | WO2007000967A1 Remedy for cerebral infarction |
| 01/04/2007 | WO2007000939A1 Therapeutic agent for local inflammation |
| 01/04/2007 | WO2007000928A1 Remedy and/or preventive for chronic heart failure |
| 01/04/2007 | WO2007000884A1 Prophylactic/therapeutic agent for bone/joint disease and screening method for the agent |
| 01/04/2007 | WO2007000779A2 Pharmaceutical sustained release compositions and processes thereof |
| 01/04/2007 | WO2007000778A2 Modified release pharmaceutical compositions on the basis of two polymers and processes thereof |
| 01/04/2007 | WO2007000771A2 Fused quinazolinone derivatives and uses thereof |
| 01/04/2007 | WO2007000764A2 Compositions and methods for enhancement of sexual function |
| 01/04/2007 | WO2007000644A1 Homomorpholine oxazolidinones as antibacterial agents |
| 01/04/2007 | WO2007000642A1 Fluoroprostaglandins nitroderivatives |
| 01/04/2007 | WO2007000641A2 Prostaglandin derivatives |
| 01/04/2007 | WO2007000582A1 Heterocyclic non-peptide gnrh antagonists |
| 01/04/2007 | WO2007000473A1 Use of phthalocyanine derivates for the non-photodynamic treatment of diseases |
| 01/04/2007 | WO2007000472A1 Self-sterilizing products |
| 01/04/2007 | WO2007000465A1 Novel 3-aza-spiro[5.5]undecane derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
| 01/04/2007 | WO2007000464A1 Novel 3-aza-spiro[5.5]undec-8-ene derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
| 01/04/2007 | WO2007000463A1 Novel 3,9-diaza-spiro[5.5]undecane derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
| 01/04/2007 | WO2007000436A1 Quinoline derivatives as antibacterial agents |
| 01/04/2007 | WO2007000435A1 Quinoline derivatives as antibacterial agents |
| 01/04/2007 | WO2007000434A1 Quinoline derivatives as antibacterial agents |
| 01/04/2007 | WO2007000432A1 Oxazolidinone derivatives and use thereof as antibiotics |
| 01/04/2007 | WO2007000393A1 8-alk0xy-4-methyl-3 , 4-dihydr0-quinaz0lin-2-yl amines and their use as 5-ht5a receptor ligands |
| 01/04/2007 | WO2007000383A1 Biphenyl and naphthyl-phenyl hydroxamic acid derivatives |
| 01/04/2007 | WO2007000339A1 Bicyclic derivatives as p38 kinase inhibitors |
| 01/04/2007 | WO2007000337A1 Bicyclic derivatives as p38 kinase inhibitors |
| 01/04/2007 | WO2007000334A1 Phenyl-pyrazole derivatives as non-steroidal glucocorticoid receptor ligands |